VIR-5500
VIR-5500-V101
Phase 1 small_molecule active
Quick answer
VIR-5500 for Hormone-refractory Prostate Cancer is a Phase 1 program (small_molecule) at Vir Biotechnology with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vir Biotechnology
- Indication
- Hormone-refractory Prostate Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active